A comparative assessment of neutropenia events, healthcare resource use, and costs among patients treated with long-acting granulocyte-colony stimulating factor in Germany

被引：0
|
作者：
Link, H. [1 ]
Thompson, S. F. [2 ]
Tian, M. [3 ]
Meise, D. [4 ]
Haas, J. S. [4 ]
Maas, C. [4 ]
Dimitrov, S. [5 ]
机构：
[1] Private Practice Haematol & Oncol, Haematol & Oncol, Kaiserslautern, Germany
[2] TEVA Pharmaceut, Oncol, Parsippany, NJ USA
[3] TEVA Pharmaceut, Oncol, W Chester, PA USA
[4] Xcenda GmbH, Oncol, Hannover, Germany
[5] TEVA Pharmaceut, Oncol, Amsterdam, Netherlands
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1678
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1706P
引用
收藏
页码：S1189 / S1189
页数：1
相关论文
共 48 条
  • [1] A comparative assessment of neutropenia events, healthcare resource use, and costs among cancer patients treated with lipegfilgrastim compared with pegfilgrastim in Germany
    Link, Hartmut
    Thompson, Stephen F.
    Tian, Marc
    Haas, Jennifer S.
    Meise, Dominic
    Maas, Christopher
    Dimitrov, Stamen
    SUPPORTIVE CARE IN CANCER, 2022, 30 (11) : 9317 - 9327
  • [2] A comparative assessment of neutropenia events, healthcare resource use, and costs among cancer patients treated with lipegfilgrastim compared with pegfilgrastim in Germany
    Hartmut Link
    Stephen F. Thompson
    Marc Tian
    Jennifer S. Haas
    Dominic Meise
    Christopher Maas
    Stamen Dimitrov
    Supportive Care in Cancer, 2022, 30 : 9317 - 9327
  • [3] How Safe Is the Administration of Long-Acting Granulocyte Colony-Stimulating Factor in Cancer Patients?
    Geissler, Klaus
    Gunzer, Matthias
    Ostermann, Helmut
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (05) : 316 - 326
  • [4] Eflapegrastim, a novel long-acting granulocyte-colony stimulating factor: Integrated safety results in patients with early-stage breast cancer treated with TC chemotherapy
    Schwartzberg, Lee S.
    Bhat, Gajanan
    Peguero, Julio
    Agajanian, Richy
    Bharadwaj, Jayaram
    Restrepo, Alvaro
    Hlalah, Osama
    Mehmi, Inderjit
    Chawla, Shanta
    Lebel, Francois
    Cobb, Patrick W.
    CANCER RESEARCH, 2020, 80 (04)
  • [5] Mechanism of action, efficacy and safety of long-acting granulocyte-colony stimulating factors (G-CSFs) in neutropenia associated with myelotoxic chemotherapy
    Rogowski, Wojciech
    ONCOLOGY IN CLINICAL PRACTICE, 2015, 11 (02): : 87 - 92
  • [6] Efbemalenograstim alfa, an Fc fusion protein, long-acting granulocyte-colony stimulating factor for reducing the risk of febrile neutropenia following chemotherapy: results of a phase III trial
    Glaspy, John
    Bondarenko, Igor
    Burdaeva, Olga
    Chen, Jianmin
    Rutty, Dean
    Li, Renshu
    Wang, Shufang
    Hou, Qingsong
    Li, Simon
    SUPPORTIVE CARE IN CANCER, 2024, 32 (01)
  • [7] Efbemalenograstim alfa, an Fc fusion protein, long-acting granulocyte-colony stimulating factor for reducing the risk of febrile neutropenia following chemotherapy: results of a phase III trial
    John Glaspy
    Igor Bondarenko
    Olga Burdaeva
    Jianmin Chen
    Dean Rutty
    Renshu Li
    Shufang Wang
    Qingsong Hou
    Simon Li
    Supportive Care in Cancer, 2024, 32
  • [8] Optimal use of pegfilgrastim (a long-acting granulocyte-colony stimulating factor [G-CSF]) to manage chemotherapy-induced febrile neutropenia (FN) in haematological malignancies: consensus guidance recommendations
    Aapro, M.
    Boccia, R.
    Choquet, S.
    Hus, I.
    Link, H.
    Sliwa, T.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S167 - S167
  • [9] A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis
    Sereno, Maria
    Maria Jimenez-Gordo, Ana
    Baena-Espinar, Javier
    Aguado, Carlos
    Mielgo, Xabier
    Pertejo, Ana
    Alvarez-Alvarez, Rosa
    Sanchez, Ana
    Luis Lopez, Jose
    Molina, Raquel
    Lopez-Alfonso, Ana
    Hernandez, Berta
    Enrique Chiara, Luis
    Manuela Martin, Ana
    Lopez-Martin, Ana
    Dorta, Miriam
    Collazo-Lorduy, Ana
    Casado, Enrique
    Ramirez de Molina, Ana
    Colmenarejo, Gonzalo
    CANCERS, 2021, 13 (16)
  • [10] Treatment Patterns, Healthcare Resource Utilization and Costs Among Schizophrenia Patients Treated with Long-Acting Injectable Versus Oral Antipsychotics
    Ankit Shah
    Lin Xie
    Furaha Kariburyo
    Qisu Zhang
    Mugdha Gore
    Advances in Therapy, 2018, 35 : 1994 - 2014
12345